YKR015C Antibody

What is YKR015C and why is it studied in yeast research?

YKR015C is a protein encoded by the YKR015C gene in Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as Baker's yeast . This protein, with UniProt accession number P36111, is part of the comprehensive yeast proteome that serves as a model system for eukaryotic cell biology . Researchers study YKR015C to understand fundamental cellular processes in eukaryotes, as the conservation of many biological pathways between yeast and higher organisms makes it an excellent model for human disease research. The study of YKR015C contributes to our understanding of protein function, localization, and interaction networks in eukaryotic cells.

What are the key specifications of commercial YKR015C antibodies?

Commercial YKR015C antibodies are typically produced against the protein from Saccharomyces cerevisiae (strain ATCC 204508 / S288c). Based on available catalog information, these antibodies are commonly supplied in 2ml or 0.1ml quantities, with specific product codes such as CSB-PA330538XA01SVG . These antibodies are designed for research applications including Western blotting, immunoprecipitation, immunohistochemistry, and ELISA. The format is usually purified immunoglobulin G (IgG) with appropriate stabilizers and preservatives to maintain activity during shipping and storage.

What sample preparation methods are recommended for YKR015C detection in yeast cells?

For optimal detection of YKR015C in yeast cells, researchers should follow these methodological steps:

• Culture Preparation: Grow S. cerevisiae cells to mid-log phase (OD600 ≈ 0.6-0.8) in appropriate media.

• Cell Lysis: Harvest cells by centrifugation and lyse using mechanical disruption (glass beads), enzymatic methods (zymolyase treatment), or chemical lysis buffers containing protease inhibitors.

• Protein Extraction: Prepare whole cell extracts, or fractionate samples to isolate specific cellular compartments depending on the research question.

• Sample Denaturation: For Western blotting, denature proteins in sample buffer containing SDS and reducing agents at 95°C for 5 minutes.

• Protein Quantification: Determine protein concentration using Bradford or BCA assays to ensure equal loading across samples.

These preparatory steps ensure consistent and reliable detection of YKR015C protein in experimental samples, which is crucial for accurate data interpretation and reproducibility.

How can YKR015C antibody be validated for cross-reactivity with other yeast species?

Validating YKR015C antibody for cross-reactivity with other yeast species requires a systematic approach:

• Sequence Alignment Analysis: Perform bioinformatic analysis of YKR015C homologs across yeast species to predict potential cross-reactivity based on epitope conservation.

• Western Blot Validation: Test the antibody against protein extracts from multiple yeast species including S. cerevisiae (positive control), related species like S. paradoxus, and more distant yeasts like Candida albicans.

• Immunoprecipitation Followed by Mass Spectrometry: Perform IP-MS to identify all proteins captured by the antibody in different species.

• Knockout Controls: Include YKR015C deletion strains as negative controls to confirm specificity.

• Pre-absorption Tests: Pre-incubate the antibody with recombinant YKR015C protein before immunostaining to demonstrate specificity through signal reduction.

This multi-faceted validation approach ensures researchers can confidently use the antibody across different yeast species or confirm its specificity to S. cerevisiae when designing comparative studies.

What are the optimal conditions for immunoprecipitation of YKR015C protein complexes?

For successful immunoprecipitation of YKR015C protein complexes, researchers should follow these methodological guidelines:

• Lysis Buffer Optimization: Use a gentle lysis buffer (e.g., 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate) with protease and phosphatase inhibitors to preserve protein-protein interactions.

• Antibody Coupling: Covalently couple the YKR015C antibody to magnetic or agarose beads using cross-linking reagents to prevent antibody contamination in the eluted sample.

• Pre-clearing Step: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Incubation Conditions: Perform immunoprecipitation at 4°C overnight with gentle rotation to maintain complex integrity while allowing efficient antigen capture.

• Washing Protocol: Use a staged washing procedure with decreasing salt concentrations to remove non-specific proteins while preserving specific interactions.

• Elution Methods: Consider native elution with competing peptides for functional studies or denaturing elution for composition analysis.

This optimized protocol maximizes the capture of native YKR015C protein complexes while minimizing background, allowing researchers to study protein-protein interactions relevant to YKR015C function in cellular pathways.

How can researchers troubleshoot poor signal intensity when using YKR015C antibody in immunofluorescence microscopy?

When encountering weak signal intensity with YKR015C antibody in immunofluorescence microscopy, researchers should systematically troubleshoot using this methodological framework:

• Fixation Optimization: Compare different fixation methods (formaldehyde, methanol, or mixed fixatives) as epitope accessibility can be fixation-dependent.

• Permeabilization Adjustment: Test various permeabilization conditions (Triton X-100, saponin, digitonin) at different concentrations to improve antibody penetration.

• Antigen Retrieval: Implement heat-mediated or enzymatic antigen retrieval methods to unmask epitopes potentially obscured during fixation.

• Antibody Concentration Titration: Perform a dilution series (1:100 to 1:2000) to identify the optimal antibody concentration that maximizes specific signal while minimizing background.

• Signal Amplification: Employ tyramide signal amplification or higher sensitivity detection systems if the protein is expressed at low levels.

• Blocking Optimization: Test different blocking agents (BSA, normal serum, casein) to reduce non-specific binding.

• Incubation Time Extension: Increase primary antibody incubation time (overnight at 4°C) to improve antigen binding.

This systematic approach often resolves signal intensity issues, allowing for successful visualization of YKR015C localization in yeast cells.

What controls should be included when designing experiments with YKR015C antibody?

A robust experimental design with YKR015C antibody requires these essential controls:

• Positive Control: Include wild-type S. cerevisiae lysate known to express YKR015C protein.

• Negative Control: Utilize one or more of the following:

  • YKR015C knockout strain lysate

  • Pre-immune serum at the same concentration as the primary antibody

  • Isotype control antibody matched to the YKR015C antibody

• Loading Control: Probe for a housekeeping protein (e.g., actin, GAPDH) to normalize protein levels across samples.

• Peptide Competition: Pre-incubate antibody with purified YKR015C peptide to demonstrate signal specificity.

• Secondary Antibody-Only Control: Omit primary antibody to assess background from secondary antibody.

• Expression Level Controls: Include samples with known altered expression levels (e.g., overexpression strains) to validate signal proportionality.

Implementation of these controls ensures experimental validity and allows confident interpretation of results by distinguishing specific signal from technical artifacts or background.

How can YKR015C antibody be used in chromatin immunoprecipitation (ChIP) experiments?

To successfully employ YKR015C antibody in ChIP experiments for studying protein-DNA interactions, researchers should follow this methodological approach:

• Crosslinking Optimization: Determine the optimal formaldehyde concentration (typically 1-3%) and crosslinking time (10-30 minutes) for YKR015C.

• Chromatin Fragmentation: Standardize sonication conditions to achieve DNA fragments of 200-500bp, verifying fragment size by agarose gel electrophoresis.

• Antibody Validation: Confirm the antibody's suitability for ChIP by performing preliminary IP experiments to ensure it can recognize crosslinked YKR015C.

• IP Protocol Specifics:

  • Use 2-5μg of YKR015C antibody per ChIP reaction

  • Include sufficient chromatin (25-100μg)

  • Perform overnight incubation at 4°C with rotation

• Washing Stringency: Implement increasingly stringent wash steps to remove non-specific DNA.

• Elution and Reversal: Optimize elution conditions and reverse crosslinks (65°C for 4-12 hours).

• DNA Purification: Employ column-based or phenol-chloroform extraction methods for purifying ChIP DNA.

• Data Analysis: Analyze enrichment by qPCR or sequencing, comparing to input chromatin and IgG control.

This detailed protocol enables researchers to map YKR015C binding sites across the yeast genome, providing insights into its potential role in transcriptional regulation or chromatin organization.

How should researchers interpret multiple bands when performing Western blot with YKR015C antibody?

When multiple bands appear in Western blots using YKR015C antibody, researchers should follow this analytical framework for interpretation:

• Expected Size Verification: Confirm the predicted molecular weight of YKR015C (based on amino acid sequence) and compare with observed bands.

• Post-translational Modifications: Consider whether higher molecular weight bands represent phosphorylated, glycosylated, ubiquitinated, or SUMOylated forms of YKR015C.

• Proteolytic Processing: Evaluate if lower molecular weight bands represent specific cleavage products with biological significance.

• Splice Variants: Research potential alternative splicing of the YKR015C gene that might produce protein isoforms.

• Oligomerization: Determine if resistant dimers or higher-order complexes explain higher molecular weight bands using non-reducing versus reducing conditions.

• Cross-reactivity: Assess potential cross-reactivity with related proteins through bioinformatic analysis.

• Validation Experiments:

  • Perform RNA interference or CRISPR knockout to confirm band specificity

  • Use different antibodies targeting distinct epitopes of YKR015C

  • Employ mass spectrometry to identify proteins in each band

This systematic interpretation process converts potentially confusing Western blot results into valuable insights about YKR015C biology and post-translational regulation.

What approaches can be used to quantify YKR015C protein expression levels in different yeast growth conditions?

For accurate quantification of YKR015C protein expression across different growth conditions, researchers should employ these methodological approaches:

• Western Blot Quantification:

  • Use infrared fluorescence-based detection systems (e.g., Odyssey)

  • Implement housekeeping protein normalization (e.g., actin, GAPDH)

  • Establish a standard curve using recombinant YKR015C protein

  • Analyze images with dedicated software (ImageJ, Image Studio)

• ELISA Development:

  • Develop a sandwich ELISA using capture and detection antibodies against different YKR015C epitopes

  • Include standard curves of recombinant YKR015C protein

  • Optimize blocking, washing, and detection conditions

• Mass Spectrometry Approaches:

  • Employ SILAC (Stable Isotope Labeling with Amino acids in Cell culture)

  • Use isobaric labeling techniques (TMT or iTRAQ)

  • Implement targeted approaches like Multiple Reaction Monitoring (MRM)

• Flow Cytometry:

  • Perform intracellular staining after fixation and permeabilization

  • Use fluorophore-conjugated anti-YKR015C antibodies

  • Analyze per-cell expression levels and population heterogeneity

• Single-Cell Immunofluorescence Quantification:

  • Capture standardized images under consistent exposure settings

  • Perform automated image analysis to quantify signal intensity

  • Correlate with cell cycle or morphological features

These complementary quantification approaches provide robust measurements of YKR015C protein expression changes in response to different growth conditions, stressors, or genetic backgrounds.

What are the key specifications for YKR015C antibody products?

Below is a comprehensive data table outlining the specifications for YKR015C antibody products available for research use:

This technical information assists researchers in selecting the appropriate antibody product for their specific experimental needs and ensuring proper handling and storage of the reagent .

How does YKR015C protein structure influence epitope selection for antibody production?

The structure of YKR015C protein plays a critical role in determining optimal epitopes for antibody production:

• Sequence Analysis: Examination of the YKR015C amino acid sequence reveals regions of high antigenicity, hydrophilicity, and surface accessibility that make ideal epitope candidates.

• Secondary Structure Considerations: Beta-turns and loop regions typically produce more accessible epitopes than alpha-helical or beta-sheet structures that may be partially buried.

• Post-translational Modification Sites: Identification and avoidance of known modification sites ensures antibodies will recognize the protein regardless of its modification state, unless specifically targeting modified forms.

• Conserved Domains: Analysis of evolutionarily conserved domains provides options for:

  • Targeting highly conserved regions for cross-species reactivity

  • Selecting species-specific regions for specificity to S. cerevisiae

• Hydrophobic Core Avoidance: Excluding regions likely to form the hydrophobic core of the protein ensures epitopes are surface-accessible in the native conformation.

This structure-based approach to epitope selection maximizes the likelihood of generating antibodies that effectively recognize YKR015C in various experimental applications while maintaining specificity.

How can YKR015C antibody be used in protein-protein interaction studies?

YKR015C antibody serves as a valuable tool in multiple protein-protein interaction methodologies:

• Co-Immunoprecipitation (Co-IP):

  • Use YKR015C antibody to capture the protein along with its interaction partners

  • Analyze co-precipitated proteins by Western blot or mass spectrometry

  • Compare results from different cellular conditions to identify dynamic interaction networks

• Proximity Ligation Assay (PLA):

  • Combine YKR015C antibody with antibodies against suspected interaction partners

  • Visualize interactions as fluorescent spots when proteins are within 40nm

  • Quantify interaction frequencies in different cellular compartments or conditions

• Bimolecular Fluorescence Complementation (BiFC):

  • Use antibody-derived recombinant fragments to validate interactions identified by BiFC

  • Confirm specificity of interactions through competitive binding studies

• Pull-down Validation:

  • Perform reciprocal pull-downs using antibodies against interaction partners

  • Validate interactions identified in large-scale studies like yeast two-hybrid screens

• Crosslinking Mass Spectrometry (XL-MS):

  • Use YKR015C antibody to enrich crosslinked complexes prior to mass spectrometry

  • Identify proximal proteins through chemical crosslinking followed by immunoprecipitation

These methodological approaches provide complementary evidence of protein-protein interactions, allowing researchers to construct comprehensive interaction networks around YKR015C and understand its functional role in cellular processes.

What are the considerations for using YKR015C antibody in high-throughput screening applications?

When implementing YKR015C antibody in high-throughput screening (HTS), researchers should address these methodological considerations:

• Assay Miniaturization and Automation:

  • Optimize antibody concentration for microplate formats (96, 384, or 1536-well)

  • Validate performance with automated liquid handling systems

  • Establish Z-factor scores >0.5 to ensure assay robustness

• Signal Detection Methods:

  • Compare fluorescence, chemiluminescence, and colorimetric detection for optimal signal-to-noise ratio

  • Select detection technology based on required sensitivity and dynamic range

  • Implement automation-compatible readout systems

• Quality Control Measures:

  • Include internal controls on each plate to normalize plate-to-plate variation

  • Establish acceptance criteria for positive and negative controls

  • Implement statistical methods for hit identification (3-sigma rule, percent inhibition thresholds)

• Screening Library Considerations:

  • Test for compound interference with the antibody-based detection system

  • Evaluate potential for false positives due to compound autofluorescence or quenching

  • Implement counter-screens to eliminate assay-specific artifacts

• Data Analysis Pipeline:

  • Develop automated image analysis workflows for visual assays

  • Implement normalization procedures to account for positional effects

  • Establish hit confirmation cascades with orthogonal assays

This systematic approach ensures that YKR015C antibody-based high-throughput screening delivers reliable, reproducible results that can effectively identify modulators of YKR015C-related pathways or processes.

What emerging technologies might enhance YKR015C antibody applications in yeast research?

Several cutting-edge technologies are poised to expand the utility of YKR015C antibody in yeast research:

• Super-Resolution Microscopy: Techniques like STORM, PALM, and STED microscopy combined with YKR015C antibodies can reveal nanoscale localization patterns previously undetectable with conventional microscopy, potentially uncovering novel subcellular compartmentalization.

• Single-Cell Proteomics: Emerging methods for protein analysis at the single-cell level will allow researchers to examine cell-to-cell variability in YKR015C expression and modifications, revealing heterogeneity within yeast populations that bulk methods obscure.

• Spatial Transcriptomics-Proteomics Integration: Combining YKR015C protein localization data with spatial transcriptomics will create multi-omics maps that correlate protein distribution with local translation activity.

• Microfluidic Antibody Platforms: Microfluidic devices for rapid, automated immunoassays will enable real-time monitoring of YKR015C dynamics in response to environmental perturbations with minimal sample requirements.

• CRISPR-Based Tagging: CRISPR-engineered epitope tags at the endogenous YKR015C locus will provide complementary approaches to validate antibody-based findings and enable live-cell imaging when combined with nanobody technology.

These technological advances will dramatically enhance the resolution, throughput, and contextual understanding of YKR015C biology in the coming years, opening new research avenues.

How might YKR015C antibody research contribute to translational applications beyond basic yeast biology?

Research utilizing YKR015C antibody has potential translational implications that extend beyond basic yeast biology:

• Model System for Human Disease: Insights from YKR015C studies may illuminate the functions of homologous proteins in human cells, potentially revealing disease mechanisms or therapeutic targets.

• Biotechnology Applications: Understanding YKR015C's role in yeast metabolism could lead to engineered strains with enhanced production capabilities for biofuels, pharmaceuticals, or other industrial products.

• Antifungal Drug Development: If YKR015C proves essential for yeast viability or virulence in pathogenic fungi, the antibody could facilitate screening for selective inhibitors as potential antifungal agents.

• Biomarker Discovery: Knowledge gained from YKR015C antibody research might identify conserved stress response pathways that could serve as biomarkers in human diseases.

• Antibody Engineering Platforms: Techniques refined through YKR015C antibody development may improve production of therapeutic antibodies against human disease targets.